$WMT $CVS: Infant ibuprofen recalled from Walmart, CVS, Family Dollar

Date: Friday, December 7th, 2018

Stock(s) mentioned: ,

Source: The Business Journals (https://www.bizjournals.com)

Summary: Walmart (NYSE:WMT) — “Equate” label, National Drug Code (NDC) 49035-125-23, lot numbers 00717009A, 00717015A and 00717024A; CVS (NYSE:CVS) …

Full article address: https://www.bizjournals.com/bizwomen/news/latest-news/2018/12/store-brand-infant-ibuprofen-recalled-from-walmart.html

Related News:

$CVS $BIIB: Biogen stock plunge shows ‘investment model in drug development is all wrong,’ says former Aetna CEO

$CVS: Bert’s March Dividend Stock Watch List

$CVS $ZS $ZEN $ZBRA $WSR: Cramer Remix: Levi’s stock is too rich to buy after its high-flying IPO

$CVS: CVS Health CEO on reducing costs: Billions in value opportunity is ‘in front of us’

$CVS: CVS Health Starts Selling CBD Products: Could This Under-the …

$CVS: Aetna Offers Assistance to Members Affected by Flooding in the …

$CURLF $CVS $GWPH $CANNX $PLPRF $CGC: Cannabis Watch: Curaleaf shines in falling cannabis sector on news of surprising CVS deal

$CVS: CVS Health Stores To Carry CBD Products From Curaleaf, Elevate

$CVS: Curaleaf Isn’t Just Selling Marijuana Anymore

$CVS: Axcentria Ph-armaceuticals

$CVS: CVS heard from its customers who use CBD, will ‘walk slowly’ in the space, CEO Larry Merlo says

Latest News:

$CMG: Chipotle Could Heat Up Following Wedbush Upgrade

$TIF: Why Tiffany Fell Short in Q4

$AVP: Jan Zijderveld

$NOK: (NOK) Alert: Johnson Fistel Launches Investigation into Nokia …

$APLE: Apple Hospitality REIT Announces April 2019 Distribution and Date …

$CMTL: Comtech Telecommunications Corp. Introduces New Micro …

$CGCBV: Navis N4 TOS Selected to Enhance Terminal Operations & Support …

$ATVI: Sekiro: Shadows Die Twice Launches Globally – Death is Not Your …

$H: Hyatt Announces Hyatt Centric Brand Growth in the US with New …

$EAST: Eastside Distilling Announces New Redneck Riviera Whiskey …

$OSIR $SNN: Questions About Osiris Therapeutics Buyout